SLS
SELLAS Life Sciences·NASDAQ
--
--(--)
--
--(--)
3.92 / 10
Netural
Analyst consensus is a single Strong Buy, yet the analyst’s historical win rate is 0% with a –10.5% average return. Fund‑flow score is 7.84, showing solid inflows overall but negative trends for block, medium, large investors; only small investors are net positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-12
InstitutionMaxim Group
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of SLS?
- SLS holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.92/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
